Cancer Vaccine: 4 Months of Life Worth $100K?

Prostate cancer vaccine, Provenge, adds 4 months to life, at a pricetag of 100K. The first-ever approved cancer vaccine, Provenge offers hope to men with advanced prostate cancer, but the high cost of this new treatment raises healthcare policy questions. Prostate cancer - Sipuleucel-T - Cancer - Cancer vaccine - Dendreon

Aggressive Treatment for Prostate Cancer Is the Norm

Title: Aggressive Treatment for Prostate Cancer Is the Norm Category: Health News Created: 7/27/2010 10:23:00 AM Last Editorial Review: 7/27/2010 10:23:35 AM

Costly New Prostate Cancer Drug Works In Mysterious Ways

A new prostate cancer treatment that uses a patient's own white blood cells to effectively create a personalized vaccine has been approved. But no one really knows how it works.

Breakthrough Breast Cancer Identifies Potential New Treatment Which Could Help 800 Scottish Women Each Year

Scientists from the Breakthrough Breast Cancer Research Unit at the University of Edinburgh have discovered a potential new way to treat a common form of breast cancer which affects 800 Scottish women and 9,000 UK women each year. The team are the first to identify a gene's key role in causing the spread of HER2 positive breast cancer to other parts of the body. The gene is called C35 and ...

Getting less than the best cancer treatment

When it comes to cancer treatment, most patients would hope to get the latest medications, delivered in line with the world's best practice.